Pliant Therapeutics, Inc. (PLRX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings ...

However, when several insiders are buying... Kodak stock jumped Tuesday after it found a lot of cash—in the company’s pension plan. Monday, Kodak said in a filing with the Securities and ...

Pliant Therapeutics will assemble an external panel of experts to review data from the ongoing Phase IIb BEACON-IPF trial of its investigational integrin inhibitor bexotegrast in idiopathic pulmonary ...

After hours: February 14 at 6:57:18 PM EST Loading Chart for KODK ...